Wendegatz E, Lettow J, Wierzbicka W, Schuller H
Curr Genet. 2025; 71(1):2.
PMID: 39820713
PMC: 11739200.
DOI: 10.1007/s00294-025-01309-w.
Vladimirova S, Kokoreva N, Guzhova I, Alhasan B, Margulis B, Nikotina A
Cancers (Basel). 2024; 16(23).
PMID: 39682216
PMC: 11640653.
DOI: 10.3390/cancers16234030.
Chesnutt K, Yayli G, Toelzer C, Damilot M, Cox K, Gautam G
Nucleic Acids Res. 2024; 53(1.
PMID: 39656677
PMC: 11724297.
DOI: 10.1093/nar/gkae1120.
Jakobsen S, Siersbaek R
Oncogene. 2024; 44(1):1-7.
PMID: 39468222
DOI: 10.1038/s41388-024-03174-2.
Rejnowicz E, Batchelor M, Leen E, Ahangar M, Burgess S, Richards M
Biochem J. 2024; 481(21):1535-1556.
PMID: 39370942
PMC: 11555651.
DOI: 10.1042/BCJ20240248.
Post-Translational Modifications (PTMs) of mutp53 and Epigenetic Changes Induced by mutp53.
Benedetti R, Di Crosta M, DOrazi G, Cirone M
Biology (Basel). 2024; 13(7).
PMID: 39056701
PMC: 11273943.
DOI: 10.3390/biology13070508.
Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2.
Vogt M, Dudvarski Stankovic N, Cruz Garcia Y, Hofstetter J, Schneider K, Kuybu F
Gut. 2024; 73(9):1509-1528.
PMID: 38821858
PMC: 11347226.
DOI: 10.1136/gutjnl-2023-331519.
A druggable conformational switch in the c-MYC transactivation domain.
Lama D, Vosselman T, Sahin C, Liano-Pons J, Cerrato C, Nilsson L
Nat Commun. 2024; 15(1):1865.
PMID: 38424045
PMC: 10904854.
DOI: 10.1038/s41467-024-45826-7.
Targeting MYC at the intersection between cancer metabolism and oncoimmunology.
Venkatraman S, Balasubramanian B, Thuwajit C, Meller J, Tohtong R, Chutipongtanate S
Front Immunol. 2024; 15:1324045.
PMID: 38390324
PMC: 10881682.
DOI: 10.3389/fimmu.2024.1324045.
Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection.
Hou J, Wei Y, Zou J, Jaffery R, Sun L, Liang S
Nat Commun. 2024; 15(1):109.
PMID: 38168026
PMC: 10761986.
DOI: 10.1038/s41467-023-44175-1.
Comparative genome-wide characterization of salt responsive micro RNA and their targets through integrated small RNA and de novo transcriptome profiling in sugarcane and its wild relative .
Vignesh P, Mahadevaiah C, Selvamuthu K, Mahadeva Swamy H, Sreenivasa V, Appunu C
3 Biotech. 2024; 14(1):24.
PMID: 38162015
PMC: 10756875.
DOI: 10.1007/s13205-023-03867-7.
Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability.
Wang Z, Cai H, Li Z, Sun W, Zhao E, Cui H
Clin Epigenetics. 2023; 15(1):192.
PMID: 38093312
PMC: 10720090.
DOI: 10.1186/s13148-023-01608-4.
The chromatin remodeling factors EP300 and TRRAP are novel SMYD3 interactors involved in the emerging 'nonmutational epigenetic reprogramming' cancer hallmark.
Fasano C, Lepore Signorile M, Di Nicola E, Pantaleo A, Forte G, De Marco K
Comput Struct Biotechnol J. 2023; 21:5240-5248.
PMID: 37954147
PMC: 10632561.
DOI: 10.1016/j.csbj.2023.10.015.
MYC function and regulation in physiological perspective.
Jha R, Kouzine F, Levens D
Front Cell Dev Biol. 2023; 11:1268275.
PMID: 37941901
PMC: 10627926.
DOI: 10.3389/fcell.2023.1268275.
Evolutionary diversity of the control of the azole response by Tra1 across yeast species.
Librais G, Jiang Y, Razzaq I, Brandl C, Shapiro R, Lajoie P
G3 (Bethesda). 2023; 14(2).
PMID: 37889998
PMC: 10849324.
DOI: 10.1093/g3journal/jkad250.
Domain architecture and protein-protein interactions regulate KDM5A recruitment to the chromatin.
Kataria A, Tyagi S
Epigenetics. 2023; 18(1):2268813.
PMID: 37838974
PMC: 10578193.
DOI: 10.1080/15592294.2023.2268813.
MYC in liver cancer: mechanisms and targeted therapy opportunities.
Liu F, Liao Z, Zhang Z
Oncogene. 2023; 42(45):3303-3318.
PMID: 37833558
DOI: 10.1038/s41388-023-02861-w.
MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products.
Chan K, Zhang S, Li G, Xu Y, Cui L, Wang Y
Aging Dis. 2023; 15(2):640-697.
PMID: 37450923
PMC: 10917530.
DOI: 10.14336/AD.2023.0520.
MYC promotes global transcription in part by controlling P-TEFb complex formation via DNA-binding independent inhibition of CDK9 SUMOylation.
Guan Q, Chen Z, Yu F, Liu L, Huang Y, Wei G
Sci China Life Sci. 2023; 66(9):2167-2184.
PMID: 37115490
PMC: 10524883.
DOI: 10.1007/s11427-022-2281-6.
The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus.
Banos A, Thomas K, Garantziotis P, Filia A, Malissovas N, Pieta A
Front Immunol. 2023; 14:1072598.
PMID: 37051253
PMC: 10083368.
DOI: 10.3389/fimmu.2023.1072598.